| Chair | Peter Stebbins, DePuy Mitek and Codman, J&J Companies | |
| Vice Chair | A.J. Meuse, Associates of Cape Cod | |
| Second Vice Chair | Michael Phalen, Boston Scientific Corporation | |
| Treasurer | Michael A. Hickey, K&L Gates LLP | |
| Secretary | Randel Richner, Neocure Group, LLC | |
Andrew Diston, Cambridge Consultants
Tracey Dodenhoff, Northeastern University
David Dykeman, Greenberg Traurig LLP
John Forbes, Grant Thornton, LLP
Jed Hall, Brown Brothers Harriman & Company
Brian Jarvis, BIT Group
Subhan Khan, St. Jude Medical
Joseph P. McManus, Cummings School of Veterinary Medicine
Tom Merle, Continuum Advanced Systems
Joe Metzger, Smith & Nephew
Michael R. Minogue, ABIOMED
Gerard Moufflet, Acceleration International
Mary Murray, Hamilton Brook Smith Reynolds, P.C.
Peter Ohanian, Philips Healthcare
Marie O’Malley, Medtronic Corporation
Mark Popovsky, MD, Haemonetics Corporation
Susan Posner, Health Advances LLC
Jonathan Rennert, ZOLL Medical
Amar Swahney, Ocular Therapeutix, Inc.
Richard M. Toselli, M.D, Sanofi
Robert J. Tosti, Brown Rudnick LLP
Tom Umbel, Hologic, Inc.
John Westwood, L.E.K. Consulting
Regulatory Advisor to the Board
Pam Weagraff, Quintiles Consulting
David D. Fleming
John Mazzola, C.R. Bard, Inc.
Josh Tolkoff, Ironwood Equity Fund
John J. Wallace
Thomas J. Sommer